Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for ...
What if AI-assisted development is less of a threat, and more of a jetpack? This month’s report tackles vibe coding, along ...
Get the latest updated list of insiders for Replimune Group, Inc. (REPL). Find out the total of insider shares held, purchased and sold.
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback